Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Politician Caught In Dietary Supplement Scandal Gets A Reprieve

Executive Summary

Rejecting US prosecutors' interpretation of the federal bribery statute, the US Supreme Court on June 27 tossed out the September 2014 conviction on corruption charges of former Virginia governor Bob McDonnell, who was caught up in a $175,000 scandal, which the justices called "distasteful" and "tawdry," involving dietary supplement maker Star Scientific, which now goes by Rock Creek Pharmaceuticals.

You may also be interested in...



Ex-governor sentenced 2 years in steroid corruption scandal

A federal district judge on 6 January showed mercy to former Virginia Governor Bob McDonnell (Republican), sentencing him to only two years in prison, followed by two years of supervised release, after he was found guilty for conspiring to use his office to promote a dietary supplement company's products in exchange for about $177,000 worth of gifts, loans and trips.

US Capitol Capsule: US must lead in combating antimicrobial resistance, group urges

The US must take the lead in a multipronged effort to combat antimicrobial resistance (AMR) and needs a well-financed, coordinated and actionable national plan with measurable goals, timelines and mechanisms for accountability, the Infectious Diseases Society of America (IDSA) declared on the eve before the start of the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington.

US Capitol Capsule: Trade officials: TTIP aims to lift small/mid-sized firm barriers

The opportunities expected to be created under the Transatlantic Trade and Investment Partnership (TTIP) could especially be valuable for small and medium-sized enterprises (SMEs), given trade barriers tend to disproportionately burden those firms, which have fewer resources than larger companies to overcome obstacles, trade officials from both sides of the Atlantic said in a new report.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC065525

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel